Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 481893, 10 pages
http://dx.doi.org/10.1155/2013/481893
Review Article

Current Concepts and Management Approaches in Nonalcoholic Fatty Liver Disease

1Division of Gastroenterology and Hepatology, Cook County Health and Hospitals System, John H. Stroger Hospital of Cook County, Rush University Medical Center, 1901 West Harrison Street, Administration Building, Suite 1450, Chicago, IL 60612, USA
2Rush Oak Park Hospital, Oak Park, IL 60642, USA

Received 16 December 2012; Accepted 29 January 2013

Academic Editors: S. A. Harrison, H. C. Lin, and S.-N. Lu

Copyright © 2013 Bashar M. Attar and David H. Van Thiel. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [41 citations]

The following is the list of published articles that have cited the current article.

  • Z. M. Younossi, M. J. Reyes, A. Mishra, R. Mehta, and L. Henry, “Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets,” Alimentary Pharmacology & Therapeutics, 2013. View at Publisher · View at Google Scholar
  • Sandra Milic, Davorka Lulic, and Davor Stimac, “Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations,” World Journal of Gastroenterology, vol. 20, no. 28, pp. 9330–9337, 2014. View at Publisher · View at Google Scholar
  • William Peverill, Lawrie W. Powell, and Richard Skoien, “Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation,” International Journal of Molecular Sciences, vol. 15, no. 5, pp. 8591–8638, 2014. View at Publisher · View at Google Scholar
  • Jesse D. Riordan, and Joseph H. Nadeau, “Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse,” Mammalian Genome, 2014. View at Publisher · View at Google Scholar
  • Roberto Catanzaro, Federica Calabrese, Sergio Occhipinti, Maria Grazia Anzalone, Angelo Italia, Michele Milazzo, and Francesco Marotta, “Nonalcoholic Fatty Liver Disease Increases Risk for Gastroesophageal Reflux Symptoms,” Digestive Diseases and Sciences, 2014. View at Publisher · View at Google Scholar
  • Andres Acosta, and Michael Camilleri, “Gastrointestinal morbidity in obesity,” Annals of the New York Academy of Sciences, 2014. View at Publisher · View at Google Scholar
  • Katherine J. P. Schwenger, “Clinical approaches to non-alcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 20, no. 7, pp. 1712–1723, 2014. View at Publisher · View at Google Scholar
  • Yusuf Yilmaz, “Obesity-Associated Nonalcoholic Fatty Liver Disease,” Clinics in Liver Disease, vol. 18, no. 1, pp. 19–+, 2014. View at Publisher · View at Google Scholar
  • Kang Huang, Xiu-ci Liang, Ying-li Zhong, Wan-yan He, and Zheng Wang, “5-Caffeoylquinic acid decreases diet-induced obesity in rats by modulating PPARα and LXRα transcription,” Journal of the Science of Food and Agriculture, 2014. View at Publisher · View at Google Scholar
  • Akira Sasaki, Hiroyuki Nitta, Koki Otsuka, Akira Umemura, Shigeaki Baba, Toru Obuchi, and Go Wakabayashi, “Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments,” Frontiers in Endocrinology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Suja Rani Sasidharan, Joshua Allan Joseph, Senthilkumar Anandakumar, Vijayabalaji Venkatesan, Chandrasekharan Nair Ariyattu Madhavan, and Amit Agarwal, “Ameliorative Potential of Tamarindus indica on High Fat Diet Induced Nonalcoholic Fatty Liver Disease in Rats,” The Scientific World Journal, vol. 2014, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Erika Wichro, Tanja Macheiner, Jasmin Schmid, Barbara Kavsek, and Karine Sargsyan, “The Wide and Complex Field of NAFLD Biomarker Research: Trends,” ISRN Hepatology, vol. 2014, pp. 1–12, 2014. View at Publisher · View at Google Scholar
  • Steven J Vander Naalt, Juan P Gurria, and AiXuan L Holterman, “Surgical treatment of nonalcoholic fatty liver disease in severely obese patients.,” Hepatic medicine : evidence and research, vol. 6, pp. 103–12, 2014. View at Publisher · View at Google Scholar
  • Chihiro Okuma, Takeshi Ohta, Hironobu Tadaki, Tatsuya Ishigure, Shohei Sakata, Hideyuki Taniuchi, Ryuhei Sano, Hiromi Hamada, Shinichi Kume, Jun Nishiu, and Makoto Kakutani, “JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis,” Journal of Pharmacological Sciences, 2015. View at Publisher · View at Google Scholar
  • Guy Bower, Thanos Athanasiou, Alberto M. Isla, Leanne Harling, Jia V. Li, Elaine Holmes, Evangelos Efthimiou, Ara Darzi, and Hutan Ashrafian, “Bariatric surgery and nonalcoholic fatty liver disease,” European Journal of Gastroenterology & Hepatology, vol. 27, no. 7, pp. 755–768, 2015. View at Publisher · View at Google Scholar
  • Savannah Tallino, Megan Duffy, Martina Ralle, María Paz Cortés, Mauricio Latorre, and Jason L. Burkhead, “,” The Journal of Nutritional Biochemistry, 2015. View at Publisher · View at Google Scholar
  • Long Zhang, Wei You, Hanze Zhang, Rui Peng, Qin Zhu, Aihua Yao, Xiangcheng Li, Yebin Zhou, Xuehao Wang, Liyong Pu, and Jindao Wu, “ PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis ,” Journal of Gastroenterology and Hepatology, vol. 30, no. 5, pp. 821–829, 2015. View at Publisher · View at Google Scholar
  • Jun-ichi Takino, Kentaro Nagamine, Masayoshi Takeuchi, and Takamitsu Hori, “In vitro identification of nonalcoholic fatty liver disease-related protein hnRNPM,” World Journal Of Gastroenterology, vol. 21, no. 6, pp. 1784–1793, 2015. View at Publisher · View at Google Scholar
  • Ha-Neul Choi, Soo-Mi Jeong, Gyung Hye Huh, and Jung-In Kim, “Quercetin ameliorates insulin sensitivity and liver steatosis partly by increasing adiponectin expression in ob/ob mice,” Food Science And Biotechnology, vol. 24, no. 1, pp. 273–279, 2015. View at Publisher · View at Google Scholar
  • Mehmet Sayiner, Aaron Koenig, Linda Henry, and Zobair M. Younossi, “Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World,” Clinics in Liver Disease, 2015. View at Publisher · View at Google Scholar
  • Amanda Chaney, “Treating the patient with nonalcoholic fatty liver disease,” The Nurse Practitioner, vol. 40, no. 11, pp. 36–42, 2015. View at Publisher · View at Google Scholar
  • Nwe Ni Than, and Philip N. Newsome, “A concise review of non-alcoholic fatty liver disease,” Atherosclerosis, 2015. View at Publisher · View at Google Scholar
  • Jun-ichi Takino, Kentaro Nagamine, Takamitsu Hori, Akiko Sakasai-Sakai, and Masayoshi Takeuchi, “Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma,” World Journal of Hepatology, vol. 7, no. 23, pp. 2459–2469, 2015. View at Publisher · View at Google Scholar
  • Xun Wang, Ming-Lin Wang, Xin-Yao Lu, Peng Zhang, Hong-Gang Yu, and Yi-Kui Hu, “Glucagon-like peptide-1 suppresses palmitic acid induced L02 cell apoptosis through JNK pathway,” World Chinese Journal of Digestology, vol. 23, no. 1, pp. 16–21, 2015. View at Publisher · View at Google Scholar
  • Yuchen Zhang, Jinyan Zhao, Xiaoyong Zhong, Haiyin Zheng, Ying Li, Liya Liu, Yun Wan, Jun Peng, and Zhenfeng Hong, “Ameliorative Potential Of Artemisia Capillaris Formula On Nonalcoholic Fatty Liver Disease In Rats Through Regulation Of Fat Metabolism,” African Journal Of Traditional Complementary And Alternative Medicines, vol. 12, no. 6, pp. 151–161, 2015. View at Publisher · View at Google Scholar
  • Maria A. Kozlova, David A. Areshidze, Lyudmila D. Timchenko, Ivan A. Syomin, and Rzhepakovsky, “Nonalcoholic steatohepatitis animal model, induced by high-fat diet and tetracycline,” Modern Applied Science, vol. 9, no. 1, pp. 170–177, 2015. View at Publisher · View at Google Scholar
  • Zhen He, Cheng Hu, and Weiping Jia, “miRNAs in non-alcoholic fatty liver disease,” Frontiers of Medicine, 2016. View at Publisher · View at Google Scholar
  • Patrick Austin, Melinda Byrns, Lynn Gerber, Pegah Golabi, Cameron T. Locklear, Sophie Afdhal, and Zobair M. Younossi, “Effectiveness of exercise in hepatic fat mobilization in nonalcoholic fatty liver disease: Systematic review,” World Journal of Gastroenterology, vol. 22, no. 27, pp. 6318–6327, 2016. View at Publisher · View at Google Scholar
  • Nicolas Calo, Pierluigi Ramadori, Cyril Sobolewski, Yannick Romero, Christine Maeder, Margot Fournier, Pia Rantakari, Fu-Ping Zhang, Matti Poutanen, Jean-François Dufour, Bostjan Humar, Serge Nef, and Michelangelo Foti, “ Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption ,” Gut, vol. 65, no. 11, pp. 1871–1881, 2016. View at Publisher · View at Google Scholar
  • Eunhui Seo, Yoon Sin Oh, and Hee-Sook Jun, “Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice,” Nutrients, vol. 8, no. 2, pp. 83, 2016. View at Publisher · View at Google Scholar
  • İlknur Bingül, A. Fatih Aydın, Canan Başaran-Küçükgergin, Işın Doğan-Ekici, Jale Çoban, Semra Doğru-Abbasoğlu, and Müjdat Uysal, “High-fat diet plus carbon tetrachloride-induced liver fibrosis is alleviated by betaine treatment in rats,” International Immunopharmacology, vol. 39, pp. 199–207, 2016. View at Publisher · View at Google Scholar
  • Shahinul Alam, Golam Mustafa, Mahabubul Alam, and Nooruddin Ahmad, “Insulin resistance in development and progression of nonalcoholic fatty liver disease,” World Journal of Gastrointestinal Pathophysiology, vol. 7, no. 2, pp. 211, 2016. View at Publisher · View at Google Scholar
  • Claudia P. Oliveira, Priscila de Lima Sanches, Erlon Oliveira de Abreu-Silva, and Aline Marcadenti, “Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease,” Journal of Diabetes Research, vol. 2016, pp. 1–12, 2016. View at Publisher · View at Google Scholar
  • Gabriela Moreira Soares, Kathia Regina Cantelli, Sandra Lucinei Balbo, Rosane Aparecida Ribeiro, Ana Claudia Paiva Alegre-Maller, Helena Cristina Barbosa-Sampaio, Antonio Carlos Boschero, Allan Cezar Faria Araújo, and Maria Lúcia Bonfleur, “Liver steatosis in hypothalamic obese rats improves after duodeno-jejunal bypass by reduction in de novo lipogenesis pathway,” Life Sciences, 2017. View at Publisher · View at Google Scholar
  • Rustu Turkay, Abdurrahman Fatih Aydin, Ilknur Bingul, Canan Kucukgergin, Isin Dogan-Ekici, Elif Hocaoglu, Ercan Inci, Baris Bakir, and Mujdat Uysal, “Can Ultrasound Imaging Predict the Success of an Experimental Steatofibrosis Model?,” Ultrasound Quarterly, vol. 33, no. 2, pp. 157–161, 2017. View at Publisher · View at Google Scholar
  • Flavia A. Cimini, Ilaria Barchetta, Simone Carotti, Laura Bertoccini, Marco G. Baroni, Umberto Vespasiani-Gentilucci, Maria-Gisella Cavallo, and Sergio Morini, “Relationship between adipose tissue dysfunction, Vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 23, no. 19, pp. 3407–3417, 2017. View at Publisher · View at Google Scholar
  • Syunsuke Watanabe, Tetsuyuki Takahashi, Hirohisa Ogawa, Hisanori Uehara, Takaaki Tsunematsu, Hayato Baba, Yuki Morimoto, and Koichi Tsuneyama, “Daily Coffee Intake Inhibits Pancreatic Beta Cell Damage and Nonalcoholic Steatohepatitis in a Mouse Model of Spontaneous Metabolic Syndrome, Tsumura-Suzuki Obese Diabetic Mice,” Metabolic Syndrome and Related Disorders, 2017. View at Publisher · View at Google Scholar
  • Gasim Ibrahim Gasim, Fahd Mohamed Elshehri, Mahmoud Kheidr, Fahad Khalid Alshubaily, ElZaki Mohamed ElZaki, and Imad R Musa, “The Use of Computed Tomography in the Diagnosis of Fatty Liver and Abdominal Fat Distribution among a Saudi Population.,” Open access Macedonian journal of medical sciences, vol. 5, no. 6, pp. 762–765, 2017. View at Publisher · View at Google Scholar
  • Jun-ichi Takino, Kentaro Nagamine, Mikoto Suzuki, Akiko Sakasai-Sakai, Masayoshi Takeuchi, and Takamitsu Hori, “Gene Expression Changes Associated with the Loss of Heterogeneous Nuclear Ribonucleoprotein M Function,” American Journal of Molecular Biology, vol. 07, no. 02, pp. 87–98, 2017. View at Publisher · View at Google Scholar
  • Wei Jia, and Cynthia Rajani, “The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease,” Obesity, Fatty Liver and Liver Cancer, vol. 1061, pp. 95–110, 2018. View at Publisher · View at Google Scholar
  • Alejandra Altamirano-Barrera, Misael Uribe, Norberto C. Chávez-Tapia, and Natalia Nuño-Lámbarri, “The role of the gut microbiota in the pathology and prevention of liver disease,” The Journal of Nutritional Biochemistry, 2018. View at Publisher · View at Google Scholar